They engineered urokinase plasminogen activator receptor (uPAR)-targeted magnetic iron oxide nanoparticles (IONPs) that delivered chemotherapy drug gemcitabine (Gem) to uPAR-expressing tumour and stromal cells, such as pancreatic cancer cells. This evidence concerns the gene PLAUR and familial pancreatic carcinoma.